86 related articles for article (PubMed ID: 4826501)
1. Prevention by testosterone of the intestinal toxicity caused by the antitumor agent 3-deazauridine.
Bloch A; Dutschman G; Grindey G; Simpson CL
Cancer Res; 1974 Jun; 34(6):1299-303. PubMed ID: 4826501
[No Abstract] [Full Text] [Related]
2. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
3. Further evaluation of diethyldithiocarbamate as an antagonist of cisplatin toxicity.
Gale GR; Atkins LM; Walker EM
Ann Clin Lab Sci; 1982; 12(5):345-55. PubMed ID: 6291445
[No Abstract] [Full Text] [Related]
4. Potential antitumor agent: steroidal bilactam ester of p-N, N-bis (2-chloroethyl) aminophenylacetic acid.
Catsoulacos P; Camoutsis C; Papageorgiou A
Anticancer Res; 1995; 15(3):827-30. PubMed ID: 7645966
[TBL] [Abstract][Full Text] [Related]
5. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
Schein PS; McMenamin MG; Anderson T
Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
[No Abstract] [Full Text] [Related]
6. Effect of platinum(II) choline complex on murine leukemias L1210 and P388.
Ochocki J; Glinka R; Cieśliński M; Góra-Tybor J; Potemski P
Pharmazie; 1997 Jul; 52(7):567-9. PubMed ID: 9266598
[No Abstract] [Full Text] [Related]
7. Studies with 8-azainosine, a cytotoxic nucleoside with antitumor activity.
Bennett LL; Vail MH; Allan PW; Laster WR
Cancer Res; 1973 Mar; 33(3):465-71. PubMed ID: 4689896
[No Abstract] [Full Text] [Related]
8. Combination of dihydroxyanthraquinone and radiation on L1210 murine leukemia.
Kimler BF; Hacker MP
Cancer Clin Trials; 1981; 4(2):173-6. PubMed ID: 7249253
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
WU FY; Le Pecq JB
Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
[No Abstract] [Full Text] [Related]
10. Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells.
Wilkoff LJ; Lloyd HH; Dulmadge EA; Dixon GJ
J Natl Cancer Inst; 1970 Jan; 44(1):201-9. PubMed ID: 11515031
[No Abstract] [Full Text] [Related]
11. Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Neil GL; Berger AE; McPartland RP; Grindey GB; Bloch A
Cancer Res; 1979 Mar; 39(3):852-6. PubMed ID: 427775
[No Abstract] [Full Text] [Related]
12. [Cytokinetic effects of 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5- dioxopiperazin-1-yl) ethane (MST-16) on leukemia L1210 cells in mice].
He H; Wang MY; Zhang TM
Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):369-73. PubMed ID: 3195349
[No Abstract] [Full Text] [Related]
13. Research on compounds with antiblastic acitvity. XXXIV. Derivatives of 3-p-aminophenyl-2-oxazolidinone: synthesis and antineoplastic activities.
Artico M; De Martino G; Giuliano R
Farmaco Sci; 1969 Feb; 24(2):179-90. PubMed ID: 5786383
[No Abstract] [Full Text] [Related]
14. [Development of leukemia L-1210 after treatment with the methionine synthetase inhibitor quinoline dibromide].
Kudriavtsev IA; Paramonova TD; Golenko OD; Miasishcheva NV
Probl Gematol Pereliv Krovi; 1982 Jul; 27(7):27-31. PubMed ID: 7122454
[No Abstract] [Full Text] [Related]
15. Comparative study of sister chromatid exchange induction and antitumor effects by homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
Camoutsis C; Catsoulacos D; Karayiann V; Papageorgiou A; Mourelatos D; Mioglou E; Kritsi Z; Nikolaropoulos S
Cancer Detect Prev; 2001; 25(6):558-64. PubMed ID: 12132876
[TBL] [Abstract][Full Text] [Related]
16. Phosphorohydrazines of 4-oxo-4H-1-benzopyran and 1-benzopyran-2,4-dione exhibit antitumor activity against L1210 leukemia.
Nawrot-Modranka J; Ochocki J; Graczyk J
Pharmazie; 2004 Sep; 59(9):731-2. PubMed ID: 15497762
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
18. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters.
Koutsourea AI; Fousteris MA; Arsenou ES; Papageorgiou A; Pairas GN; Nikolaropoulos SS
Bioorg Med Chem; 2008 May; 16(9):5207-15. PubMed ID: 18353651
[TBL] [Abstract][Full Text] [Related]
19. Guanylhydrazones with potential antileukemic activity. 1. Aza analogs of 4,4'-diacetyldiphenylurea bis(guanylhydrazone).
Korytnyk W; Ghosh AC; Angelino N; Dave C
J Med Chem; 1973 Aug; 16(8):959-61. PubMed ID: 4795701
[No Abstract] [Full Text] [Related]
20. Effectiveness of antitumor agents administered subcutaneously to L1210 leukemic mice in silicone rubber devices.
Neil GL; Scheidt LG; Kuentzel SL; Moxley TE
Chemotherapy; 1973; 18(1):27-40. PubMed ID: 4681847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
